The pharma and life sciences sector continues to advance through operational performance, scientific innovation, and recognition of industry expertise. Organisations are navigating complex markets while driving breakthroughs that impact patients, research, and global healthcare.

Strong performance demonstrates resilience and strategic focus. Teva’s Irish arm posts rising profits despite lower revenues highlights the ability of companies to optimise operations, maintain profitability, and invest in ongoing growth even amid challenging market conditions.

Scientific innovation is shaping the sector’s trajectory. How SGS is advancing scientific excellence showcases the vital role of rigorous testing, analytical capabilities, and adaptive research strategies in supporting the biopharma landscape and meeting evolving industry standards.

Meanwhile, Nuala Calnan to bring expertise to judging panel for the Pharma Industry Awards 2025, highlighting best-in-class practices and bringing more than 2 decades of leadership and expertise in the medtech and biopharmaceutical sectors.

These developments reflect a sector where performance, scientific advancement, and leadership converge to drive innovation, operational excellence, and sustainable impact.

Explore the full stories and stay informed on the breakthroughs shaping modern pharma and life sciences.